Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

—A—
abstract, section 5, section 9
acceptance, section 9
alternative hypothesis, section 5
analysis of variance, section 8
AOA funding, section 6, appendix D

—B—
bibliography, section 5
BIOSIS Previews, section 3

—C—
case control study, section 5, appendix M
category variables, section 8
cause-effect relationship, section 5
checklist, section 1
chi-square test, section 8
cluster sampling, section 5
cohort study, section 5, appendix M
COM funding, section 6, appendix B
conclusion, section 9
confidence interval, section 5, section 8
conflict of interest, appendix I
consent form, appendix L
continuous, section 8
continuous variables, section 5, section 8
control group, section 5
control variable, section 5
convenience sampling, section 5
correlation, section 8
cross tabulation, section 8
cross-sectional study, section 5, appendix M

—D—
data analysis, section 8, section 8
data base, appendix B
data cleaning, section 8
data coding, section 8
data entry, section 8
data management, section 8
dependent variable, section 5
dichotomous variables, section 8
discussion, section 9
distribution, section 8
drug testing protocols, section 2
drug trial, section 2

—E—
effect size, section 5
ethical considerations, section 9
experimental design, appendix M
experimental study, section 5
external funding, section 6

—F—
frequency distribution, section 8
F-test, section 8
funding, section 6, appendix B, appendix C, appendix D

—G—
grants, section 3

—H—
human subjects, section 5
hypothesis, section 5

—I—
incidence, section 5
independent variable, section 5
Index Medicus, section 3
informed consent, section 5
Institutional Review Board, appendix K
Institutional Review Board (IRB), section 5
introduction, section 9

—L—
literature review, appendix A
literature search, section 3

—M—
manuscript preparation, section 9
mean, section 8
median, section 8
MEDLARS, section 3
MEDLINE, section 3
methods, section 9
mode, section 8
multistage sampling, section 5

—N—
National Institutes of Health, appendix E
National Library of Medicine, section 3
nominal, section 8
non-probability sampling, section 5
null hypothesis, section 5

—O—
observational studies, section 5
odds ratio, section 8
oral presentation, section 9
ordinal, section 8
OU funding, section 6, appendix C
outliers, section 8

—P—
P value, section 8
poster presentation, section 9
power, section 5
prevalence, section 5
principal investigator, section 2
probability sampling, section 5
proposal, section 5
prospective, appendix M
publication, section 9
purposive sampling, section 5

—Q—
qualitative research, appendix O
quasi-experimental design, appendix M
quasi-experimental study, section 5
quota sampling, section 5

—R—
range, section 8
references, section 9, references
rejection, section 9
research design, section 5, appendix M
Research Health & Safety Checklist, appendix G
results, section 9
retrospective, appendix M
risk ratio, section 8

—S—
sample size, section 5
sampling techniques, section 5
sensitivity, section 5
significance level (P), section 5
simple random sampling, section 5
specificity, section 5
standard deviation, section 8
statistical analysis, section 8
statistical packages, section 8
stratified random sampling, section 5
survey research, appendix N
systematic sampling, section 5

—T—
title, section 9
Transmittal Form, appendix F

—V—
variable, section 5
variables, section 8
variance, section 5, section 8

Return to appendix N

Return to Table of Contents